Background. - Blood C-reactive protein levels have been frequently fou
nd to be increased after Curosurf(R) instillation. These variations ha
ve been compared to tile values after Surfexo(R) therapy and after abs
ence of surfactant therapy. Population and methods. - The files of not
infected premature babies, aged 25 to 36 weeks of gestational age, un
der mechanical ventilation for a hyaline membrane disease (HMD), admit
ted in our unit between January 1990 to June 1995, have been retrospec
tively studied. They, were separated into three groups: A: 67 infants
ventilated for more than 5 days for HMD without surfactant therapy; B:
23 infants treated by Surfexo(R) C: 60 infants treated by Curosurf(R)
. CRP was measured daily between day 0 (D0) and D5. Means and standard
deviations were calculated for each day and each group. The mean valu
es of CRP at D1 to D5 in group C were compared to D0. The daily CRP va
lues were compared in the three groups. For group C, the results were
studied daily according to the gestational age, dosage and age of the
neonate at the first instillation. The statistical results have been g
iven according to the Student t test. Results. - After Curosurf(R), th
e mean CRP value rose significantly from D1 to D4 compared to D0. Ther
e was no difference of CRP between groups A and B from D0 to D5. Group
C had higher values in comparison to group A (between D1 to D5) and t
o group B (between D1 and D3). There was no significant difference of
the CRP values in group C according to the number of instillations or
the amount instilled, but CRP was lower in early treated infants (< H6
). Discussion. - Curosurf(R) instillation is followed by a significant
increase in CRP, maximum at D2. This is not seen after Surfexo(R). Th
is increase seems less important at D2-D3 when Curosurf(R) is administ
ered early. The CRP increase after Curosurf(R) therapy could be due to
an inflammatory reaction to the heterologous proteins it contains.